DIMERIX LIMITED
ASX:DXBPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 97.5% of what they think they own, once every option and right converts.
Runway 2–4 quarters; share count grew 8% in 24 months
DIMERIX LIMITED's ordinary share count grew 9.0% between September 2024 and October 2025, reaching 600M shares. The company has not raised capital in the past 24 months and has no pending proposed securities issues. Options and rights on issue could convert into 16M new shares, representing 2.6% of the current share count, with none currently in the money. An expiry date for these securities is not on record. As of the June 2026 quarter, DIMERIX LIMITED reported A$21.7M in available cash, sufficient for approximately 2.1 quarters of operations.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 12 Dec 2025 | 3G · unquoted | DXB : ORDINARY FULLY PAID | 600.4M | Appendix 3G |
| 22 Oct 2025 | 2A · quoted issue | DXB : ORDINARY FULLY PAID | 600.4M | Appendix 2A |
| 12 Aug 2025 | 2A · quoted issue | DXB : ORDINARY FULLY PAID | 600.2M | Appendix 2A |
| 1 July 2025 | 2A · quoted issue | DXB : ORDINARY FULLY PAID | 600.1M | Appendix 2A |
| 27 June 2025 | 2A · quoted issue | DXB : ORDINARY FULLY PAID | 598.5M | Appendix 2A |
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 15.6M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| DXBAX | Options | Price-triggered | — | — | 15.6M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 12 Dec 2025 | Clinton Snow | Other incentive | — | 300k | — | $96k | 3Y notice |
| 12 Dec 2025 | Hugh Alsop | Other incentive | — | 300k | — | $96k | 3Y notice |
| 12 Dec 2025 | Mark Diamond | Other incentive | — | 300k | — | $96k | 3Y notice |
| 12 Dec 2025 | Nina Webster | Other incentive | 123k | 3.3M | — | $1.1M | 3Y notice |
| 12 Dec 2025 | Sonia Poli | Other incentive | 633k | 300k | — | $96k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.